title: Long-term infliximab therapy is needed for sustained steroid-free remission in patients with ulcerative colitis.
authors.affiliation: Gastorenterology Unit, CHU Pontchaillou, University of Rennes 1, France.
authors.forename: Florence
authors.initials: F
authors.lastname: Le Roy
authors.affiliation: Gastorenterology Unit, CHU Pontchaillou, University of Rennes 1, France; INSERM U991, University of Rennes 1, France.
authors.forename: Laurent
authors.initials: L
authors.lastname: Siproudhis
authors.affiliation: Gastorenterology Unit, CHU Pontchaillou, University of Rennes 1, France.
authors.forename: Jean-François
authors.initials: JF
authors.lastname: Bretagne
authors.affiliation: Gastorenterology Unit, CHU Pontchaillou, University of Rennes 1, France; INSERM U991, University of Rennes 1, France. Electronic address: guillaume.bouguen@free.fr.
authors.forename: Guillaume
authors.initials: G
authors.lastname: Bouguen
mesh_terms: D000305:Adrenal Cortex Hormones / Q000627:therapeutic use*; D003093:Colitis, Ulcerative / Q000188:drug therapy*; D005765:Gastrointestinal Agents / Q000008:administration & dosage*; D006801:Humans; D000069285:Infliximab / Q000008:administration & dosage*; D053208:Kaplan-Meier Estimate; D060046:Maintenance Chemotherapy; D016016:Proportional Hazards Models; D012008:Recurrence; D012074:Remission Induction; D012189:Retrospective Studies; D016896:Treatment Outcome
chemical_list: D000305:Adrenal Cortex Hormones; D005765:Gastrointestinal Agents; D000069285:Infliximab